Development of a sporozoite malaria vaccine.
D000595:Amino Acid Sequence; D000818:Animals; D000917:Antibody Formation; D000953:Antigens, Protozoan / Q000276:immunology*; D000954:Antigens, Surface / Q000235:genetics / Q000276:immunology*; D002460:Cell Line; D000939:Epitopes; D006801:Humans; D007110:Immunity, Active; D007371:Interferon-gamma / Q000494:pharmacology; D008099:Liver / Q000469:parasitology; D008288:Malaria / Q000276:immunology / Q000517:prevention & control*; D009842:Oligopeptides / Q000276:immunology; D010961:Plasmodium / Q000276:immunology*; D010962:Plasmodium berghei / Q000254:growth & development / Q000276:immunology; D010963:Plasmodium falciparum / Q000276:immunology; D010966:Plasmodium vivax / Q000254:growth & development; D011487:Protein Conformation; D015800:Protozoan Proteins; D011994:Recombinant Proteins / Q000494:pharmacology; D014612:Vaccines / Q000276:immunology*
D000953:Antigens, Protozoan; D000954:Antigens, Surface; D000939:Epitopes; D009842:Oligopeptides; D015800:Protozoan Proteins; D011994:Recombinant Proteins; D014612:Vaccines; C041595:circumsporozoite protein, Protozoan; D007371:Interferon-gamma